Skip to content

Clinical evaluation of the safety and the usefulness of robot assisted distal gastrectomy with nodal dissection for early gastric cancer

Clinical evaluation of the safety and the usefulness of robot assisted distal gastrectomy with nodal dissection for early gastric cancer - Clinical evaluation of the safety and the usefulness of RADG

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000010877
Enrollment
10
Registered
2013-06-04
Start date
2013-06-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stage IA early gastric cancer

Interventions

Sponsors

Department of Digestive Surgery and Surgical Oncology, Yamaguchi University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Histologically confirmed gastric cancer 2) Diagnosed as Stage IA early gastric cancer 3) Endoscopic submucosal dissection is not indicated 4) Tumor location is within the resected area by distal gastrectomy 5) No duodenal invasion 6) Over 20 years of age 7) Eeatern clinical oncology group performans status is 0 or 1 8) Body mass index is lower than 30 9) No previous upper laparotomy 10) Fulfil all following conditions WBC > 3,000/mm3 Plt > 100,000/mm3 AST < 100 IU/L ALT < 100IU/L T.Bil < 2.0 g/dl Cre < 1.5mg/dl 11) Provision of written informed consent

Exclusion criteria

Exclusion criteria: 1) Having other active cancers 2) Possibly pregnant, or breast feeding woman 3) With psychiatric disorder 4) Receiving steroids 5) With acute myocardial infaction in 6 months or with unstable ungina 6) With uncontrolled hypertention 7) With uncontrolled diabetes mellitus 8) With pulmonary disease requiring continuous oxygen therapy

Design outcomes

Primary

MeasureTime frame
The incidence of post-operative intra-abdominal infectious complications (anastomotic leakage, pancreas related infection, and intra-abdominal abscess)

Secondary

MeasureTime frame
Oveall survival Relapse free survival Completion rate of robot assised surgery The incidence of adverse event

Countries

Japan

Contacts

Public ContactShigefumi Yoshino

Yamaguchi University Graduate School of Medicine Department of Digestive Surgery and Surgical Oncology

0836-22-2264

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026